LAKE FOREST, Calif., May 15 /PRNewswire/ -- Orqis Medical Corporation announced today that Ken Charhut, President and Chief Executive Officer, will present at the 2007 Citigroup Healthcare Conference at The Hilton Hotel in New York. The presentation will detail Orqis Medical's progress in the development of its Cancion(R) System to treat decompensated heart failure and the Exeleras(R) System to treat chronic heart failure. Charhut is scheduled to speak at 9:00 am (EDT) on Wednesday, May 23, 2007.
About Heart Failure
Almost 5 million Americans -- and 14 million worldwide -- suffer from heart failure, a condition in which the heart becomes weakened and cannot pump blood efficiently. Heart failure is caused by coronary artery disease, past myocardial infarctions and other underlying cardiovascular disorders, and it is characterized by shortness of breath and edema. Improved therapies are crucial to advancing heart failure treatment, a disease that causes more than one million of hospitalizations each year and costs the U.S. healthcare system alone more than $33 billion annually.
About Orqis Medical Corporation
Orqis Medical Corporation is a privately held, clinical-stage medical device company seeking to redefine heart failure therapy by developing products that prevent or reverse underlying disease progression and provide new treatment options to the clinical community to improve patient outcomes and quality of life.
The company's percutaneous Cancion System, for the treatment of decompensated heart failure, is CE marked and is currently under an investigational device exemption (IDE) investigation in the United States in the MOMENTUM Pivotal Trial. The company's implantable Exeleras System, about the size of an implantable cardioverter defibrillator (ICD), is designed to treat mid- to late-stage chronic heart failure patients. First clinical use of this system is planned later this year. For more information on Orqis Medical, please visit http://www.orqis.com and for the MOMENTUM Trial, please visit: http://www.momentumtrial.com.
Orqis Medical CorporationCONTACT: media, Brian McIntee, Director of Marketing, +1-949-268-0184, orfinanicial, John M. Markovich, Chief Financial Officer, +1-949-268-0552,both of Orqis Medical Corporation
